Second phase III trial of MED2002 for the Treatment of Erectile Dysfunction (ED)
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2018
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Erectile dysfunction
- Focus Registrational; Therapeutic Use
- Sponsors Futura Medical
- 14 Mar 2018 According to a Futura Medical media release, Interim pharmacokinetic data indicates that at least two higher strength doses of MED2002 are eligible for the planned Phase III studies (this and profile 283164) compared with the dose used in the successful Phase II study.
- 01 Dec 2017 New trial record
- 29 Nov 2017 According to a Futura Medical media release, data from the PK study (profile 283168) will determine the dosages to be used in this and other trial (see profile 283164).